Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Systematic Review

Published on 17 Feb 2026

The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis

in Lipids in Cardiovascular Disease

Katie Kyan
Jeffrey Gornbein
Jeffrey Saver

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1769430

661 views

Systematic Review

Accepted on 16 Feb 2026

Efficacy and Safety of Lipoprotein(a)-Targeted Therapeutics: A systematic review and network meta-analysis

in Lipids in Cardiovascular Disease

Jiaqiang Hu
Jun Wang
Haixia Zhang
Yaxi Jiang
Lihua Deng
Enwu Long
Song Liu

Frontiers in Cardiovascular Medicine

Original Research

Accepted on 16 Feb 2026

From Lipid Dysbalance to Cardiorenal Decompensation: ApoB/ApoA1 Ratio Is Associated with Acute Cardiorenal Injury in CAD Patients

in Lipids in Cardiovascular Disease

Liting Pang
Chaoyi Wang
Wenjing Zhao
Lei Cai
Changjie Yu
Sheng Qiu
Qianying Xie

Frontiers in Cardiovascular Medicine

Original Research

Accepted on 16 Feb 2026

Exploratory observational study with Two-Year Outcomes of Early In-Hospital Evolocumab in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Grafting

in Lipids in Cardiovascular Disease

Giuseppe Nasso
Walter Vignaroli
Giuseppe Santarpino
Claudio Larosa
Isabella Rosa
Francesco Bartolomucci
Vincenzo Montemurro
Flavio Fiore
Antongiulio Valenzano
Giacomo Errico

Frontiers in Cardiovascular Medicine

Original Research

Published on 06 Feb 2026

Analysis of the association between SLCO1B1 gene polymorphisms and coronary heart disease risk in southern Han Chinese population and statin responses in the elderly

in Lipids in Cardiovascular Disease

Youmin Long
Yanling Liang
Chuying Lin
Guangtie Liang
Guohao Li
Zhuoran Li
Xiuxia Lei

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1645446

427 views

Original Research

Accepted on 05 Feb 2026

Serum lipoprotein(a) and risk of contrast-induced nephropathy in patients with type 2 diabetes mellitus

in Lipids in Cardiovascular Disease

Yesheng Ling
Yang Chen
Xainguan Yu
Ximei Zhang

Frontiers in Cardiovascular Medicine

Case Report

Accepted on 02 Feb 2026

Intensive Lipid-Lowering Therapy–Related Regression of a Vulnerable Plaque Confirmed by Serial Optical Coherence Tomography: A Case Report

in Lipids in Cardiovascular Disease

Junru Qu
Kun Liu
Neil Johnson
Kenji Wagatsuma
Yingying Su
Beibei Du
Yuquan He

Frontiers in Cardiovascular Medicine

143 views

Systematic Review

Published on 02 Feb 2026

Bibliometric analysis of studies on the lipid management of coronary heart disease from 2014 to 2023

in Lipids in Cardiovascular Disease

Si-Qi Liu
Xin-Yu Ji
Shu-Han Zhao
Hai-Yi Liang
Fu-Yi Yang
Yuan-Hui Hu
Shuai Shi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1513576

573 views

Original Research

Published on 30 Jan 2026

Cross-sectional analysis of adult fatty liver prevalence in Wenshan, China: an epidemiologic study using ultrasound and laboratory assessments

in Lipids in Cardiovascular Disease

Guangpin Zeng
Guanghong Li
Xinghong Lin
Shoude Yang
Linran Zeng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1571261

462 views

Original Research

Published on 30 Jan 2026

Nonlinear HbA1c thresholds reveal accelerated atherogenic remodeling and improved risk reclassification in type 2 diabetes

in Lipids in Cardiovascular Disease

Vehbi Şirikçi
Hüseyin Avni Fındıklı

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1751404

1,005 views

Original Research

Accepted on 26 Jan 2026

Lipid management in high cardiovascular risk patients in France: A comparison with rest of Europe patients from 1-year follow-up of SANTORINI

in Lipids in Cardiovascular Disease

Jean FERRIERES
Kausik K Ray
Alberico Luigi Catapano
Radhouan Allouche
Christian Becker
Aurélie Bardet
Michel Farnier

Frontiers in Cardiovascular Medicine

420 views

Case Report

Published on 13 Jan 2026

Case Report: Elevated Lp(a) as a cause of severe ASCVD in a healthy veteran athlete with low calculated QRISK3 score

in Lipids in Cardiovascular Disease

Jonathan Clark-McKellar
Tracey Keteepe-Arachi
Peter Fitzgerald
Mark W. Ruddock

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1688597

1,241 views

Original Research

Accepted on 12 Jan 2026

Novel Lipid Parameters for Predicting and Interpreting the Severity of Coronary Artery Lesions in premature coronary artery disease

in Lipids in Cardiovascular Disease

Hui Song
Kang Zhang
Yongjie Yan
Fangjie Hou

Frontiers in Cardiovascular Medicine

188 views

Perspective

Published on 09 Jan 2026

Lipoprotein(a): the neglected risk factor in cardiovascular health

in Lipids in Cardiovascular Disease

Allister Irvine
Joanne Watt
Mary Jo Kurth
Laura Mooney
Jonathan Clark-McKellar
Tracey Keteepe-Arachi
John V. Lamont
Le Roy Dowey
Peter Fitzgerald
Mark W. Ruddock

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1710557

1,993 views

Original Research

Published on 08 Jan 2026

Association between triglyceride levels and hypertension in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cross-sectional study

in Lipids in Cardiovascular Disease

Zhanqun Gao
Yubo Gao
Chao Fang
Chen Zhao
Dirui Zhang
Wei Hao
Haibo Jia
Sining Hu
Bo Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1734117

673 views

Review

Published on 16 Dec 2025

Dysfunctional high-density lipoprotein: an updated review

in Lipids in Cardiovascular Disease

Frances W. Ouyang
Huan-Hsing Chiang
Wen-Li Hsu
Ming-Hsien Tsai
Chun-Yao Huang
Alan T. Remaley
Omer Akyol
Chu-Huang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1713387

2,295 views
1 citation

Correction

Published on 26 Nov 2025

Correction: lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

in Lipids in Cardiovascular Disease

Diana Rodríguez-Espinosa
Elena Cuadrado-Payán
Laura Morantes
Miquel Gomez
Francisco Maduell
José Jesús Broseta

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1744975

562 views

Original Research

Published on 17 Nov 2025

The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and abdominal aortic calcification in adults: a cross-sectional study

in Lipids in Cardiovascular Disease

Jiawei Zhang
Yijie Ning
Rui Bai
Liying Song
Hongqin Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1578407

1,197 views

Review

Published on 29 Oct 2025

From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health

in Lipids in Cardiovascular Disease

Claudia Reytor-González
Emilia Cevallos-Fernández
Belén Jácome
Daniel Simancas-Racines

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1655889

2,639 views

Systematic Review

Published on 29 Oct 2025

Effectiveness of combining PCSK9 inhibitors with statins on major adverse cardiovascular events and lipid levels in patients after percutaneous coronary intervention: a systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Zhantao Cao
Ningjing Chen
Jun Chen
Xuejing Xu
Zhanglu Zhang
Yunsu Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1612095

2,789 views

Review

Published on 24 Oct 2025

LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review

in Lipids in Cardiovascular Disease

Omer Akyol
Huan-Hsing Chiang
Alan R. Burns
Chao-Yuh Yang
Darren G. Woodside
Tatsuya Sawamura
José Luis Sánchez-Quesada
Antonio M. Gotto
Chu-Huang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1649759

4,573 views

Case Report

Published on 20 Oct 2025

Case Report: Beating the assumed prognosis: homozygous familial hypercholesterolemia with unexpected long survival

in Lipids in Cardiovascular Disease

Lukáš Zlatohlávek
Jana Becherová Beňová
Tereza Foglarová
Tereza Dudková
Jaroslav A. Hubáček

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1643771

1,623 views

Original Research

Published on 03 Oct 2025

Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health cohort

in Lipids in Cardiovascular Disease

Behnaz Esmaeili
Shahnaz Esmaeili
Noushin Fahimfar
Mostafa Rezaei Tavirani
Farideh Razi
Iraj Nabipour
Patricia Khashayar
Fatemeh Bandarian

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1483778

1,612 views
1 citation

Case Report

Published on 22 Sep 2025

PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report

in Lipids in Cardiovascular Disease

Yuan Li
Huiyan Jiang
Yajuan Xiong
Simin Yan
Xin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1644145

2,645 views

288 articles

articles

The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis

Efficacy and Safety of Lipoprotein(a)-Targeted Therapeutics: A systematic review and network meta-analysis

From Lipid Dysbalance to Cardiorenal Decompensation: ApoB/ApoA1 Ratio Is Associated with Acute Cardiorenal Injury in CAD Patients

Exploratory observational study with Two-Year Outcomes of Early In-Hospital Evolocumab in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Grafting

Analysis of the association between SLCO1B1 gene polymorphisms and coronary heart disease risk in southern Han Chinese population and statin responses in the elderly

Serum lipoprotein(a) and risk of contrast-induced nephropathy in patients with type 2 diabetes mellitus

Intensive Lipid-Lowering Therapy–Related Regression of a Vulnerable Plaque Confirmed by Serial Optical Coherence Tomography: A Case Report

Bibliometric analysis of studies on the lipid management of coronary heart disease from 2014 to 2023

Cross-sectional analysis of adult fatty liver prevalence in Wenshan, China: an epidemiologic study using ultrasound and laboratory assessments

Nonlinear HbA1c thresholds reveal accelerated atherogenic remodeling and improved risk reclassification in type 2 diabetes

Lipid management in high cardiovascular risk patients in France: A comparison with rest of Europe patients from 1-year follow-up of SANTORINI

Case Report: Elevated Lp(a) as a cause of severe ASCVD in a healthy veteran athlete with low calculated QRISK3 score

Novel Lipid Parameters for Predicting and Interpreting the Severity of Coronary Artery Lesions in premature coronary artery disease

Lipoprotein(a): the neglected risk factor in cardiovascular health

Association between triglyceride levels and hypertension in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cross-sectional study

Dysfunctional high-density lipoprotein: an updated review

Correction: lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and abdominal aortic calcification in adults: a cross-sectional study

From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health

Effectiveness of combining PCSK9 inhibitors with statins on major adverse cardiovascular events and lipid levels in patients after percutaneous coronary intervention: a systematic review and meta-analysis

LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review

Case Report: Beating the assumed prognosis: homozygous familial hypercholesterolemia with unexpected long survival

Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health cohort

PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report